Detalhe da pesquisa
1.
Heparin Dosing During Percutaneous Coronary Intervention and Obesity.
J Cardiovasc Pharmacol
; 83(3): 251-257, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38086077
2.
The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial.
Pharmacogenomics J
; 23(6): 169-177, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37689822
3.
Measures of social deprivation and outcomes after percutaneous coronary intervention.
Catheter Cardiovasc Interv
; 101(6): 995-1000, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36994863
4.
Social deprivation index and ischemic events after percutaneous coronary intervention in patients with diabetes mellitus.
Catheter Cardiovasc Interv
; 99(4): 1015-1021, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094474
5.
Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.
Crit Care Med
; 48(9): e783-e790, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32459672
6.
Intensified P2Y12 inhibition for high-on treatment platelet reactivity.
J Thromb Thrombolysis
; 50(3): 619-627, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32152791
7.
A comprehensive review and meta-analysis of risk factors for statin-induced myopathy.
Eur J Clin Pharmacol
; 74(9): 1099-1109, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29785580
8.
IL-1R (Interleukin-1 Receptor) Signaling and Attenuated Hepatic CYP (Cytochrome P450) 2C Expression: Explanation for Higher Rate of Clopidogrel Resistance in Patients With Diabetes Mellitus?
Arterioscler Thromb Vasc Biol
; 40(6): 1429-1431, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32459538
9.
Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrel.
Platelets
; 26(4): 358-63, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-24833046
10.
Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.
J Thromb Thrombolysis
; 38(3): 380-7, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24510702
11.
Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin.
Platelets
; 24(2): 145-50, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22385219
12.
Analysis of the Combined Effect of rs699 and rs5051 on Angiotensinogen Expression and Hypertension.
bioRxiv
; 2023 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37066278
13.
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y12 Inhibitor Prescribing After Percutaneous Coronary Intervention.
Clin Pharmacol Ther
; 113(3): 615-623, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36306392
14.
Isolated Right Ventricular Myocardial Infarction Presenting With Anterior ST-Segment Elevation.
JACC Case Rep
; 4(9): 556-558, 2022 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35573845
15.
MicroRNA sequencing in patients with coronary artery disease - considerations for use as biomarker for thrombotic risk.
Clin Transl Sci
; 15(8): 1946-1958, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35643946
16.
Antithrombotic Strategy After Transcatheter Aortic Valve Replacement: A Network Meta-Analysis.
Curr Probl Cardiol
; 47(12): 101348, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944749
17.
CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings.
J Am Heart Assoc
; 11(4): e024159, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35156424
18.
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
Clin Pharmacol Ther
; 109(3): 705-715, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32897581
19.
Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study.
Platelets
; 21(5): 360-7, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20377327
20.
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention.
Clin Pharmacol
; 12: 35-41, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32368161